BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• 

  Deals

  Newly Formed Company Gains Celgene, Versant Ventures Backing

  December 19, 2016

   · 

  3 min read
• Biotech Bay

  Why Don’t More Biotech Startups Succeed? Merck & Co. Might Have A Solution

  December 19, 2016

   · 

  1 min read
• Policy

  Maquet Cardiovascular LLC Files Suit Against Saphena Medical and Dr. Albert Chin to Protect its Intellectual Property

  December 19, 2016

   · 

  3 min read
• Business

  Jaguar Animal Health Appoints Dr. Ari Azhir To Board Of Directors

  December 19, 2016

   · 

  5 min read
• Business

  Eagle Pharma Announces David Pernock As President And Chief Commercial Officer

  December 19, 2016

   · 

  5 min read
• FDA

  NovoCure’s Optune (NovoTTF-100A) Approved In Japan For The Treatment Of Newly Diagnosed Glioblastoma

  December 19, 2016

   · 

  7 min read
• Policy

  ProMetic Life Sci Initiates Rolling Submission Of Its Biologics License Application (“BLA”) For Plasminogen With U.S. FDA

  December 19, 2016

   · 

  5 min read
• Business

  Shionogi And Purdue Pharma L.P. Establish Alliance For Joint U.S. Commercialization Of Naldemedine

  December 19, 2016

   · 

  5 min read
• Drug Development

  SAGE Therapeutics Announces Initiation Of Phase 2 Clinical Development For SAGE-217 In Mood Disorders

  December 19, 2016

   · 

  8 min read
• FDA

  Merck & Co. Release: KEYTRUDA (Pembrolizumab) Approved As First Anti-PD-1 Therapy In Japan For First-Line Treatment Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express High Levels Of PD-L1

  December 19, 2016

   · 

  13 min read